APA

Rejas G. J., Sicras M. A., Navarro A. R. & De L. J. A. (20160610). Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In Spain. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chicago

Rejas Gutiérrez J, Sicras Mainar A, Navarro Artieda R and De Lossada Juste A. 20160610. Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In Spain. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Harvard

Rejas G. J., Sicras M. A., Navarro A. R. and De L. J. A. (20160610). Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In Spain. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

MLA

Rejas Gutiérrez J, Sicras Mainar A, Navarro Artieda R and De Lossada Juste A. Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In Spain. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20160610.